Drimva

Flagship Pioneering

Senior Director, LNP Formulation & Process Development

$213K–$280K

Cambridge, MA USA +1 · Director · Full-time · Posted Oct 22, 2026

Location
Cambridge, MA USA
Mirai Bio
Experience
12+ years with a Ph.D.; 14+ years with an M.S.; or 16+ years with a B.S.
Education
Ph.D. in Pharmaceutical Sciences, Chemical Engineering, Bioengineering, Chemistry, Biochemistry, or related field; or M.S.; or B.S.

About the job

Leads LNP formulation, process development, and non-GMP small-scale production for partner and internal research and preclinical programs.

What you'll do

  • Set technical strategy and oversee LNP formulation, process development, characterization, troubleshooting, and production across programs.
  • Lead and develop the LNP team, managing priorities, resources, capacity, and organizational growth.
  • Serve as a senior technical contact for clients and partners, and collaborate across functions on program delivery.

What they ask for

  • Ph.D. in a related field with 12+ years of relevant industry experience; or M.S. with 14+ years; or B.S. with 16+ years.
  • Extensive hands-on LNP formulation and process development experience, including understanding of composition, formation, purification, characterization, and process–product relationships.
  • Demonstrated ability to lead complex technical programs, interpret data, troubleshoot, and establish development strategies.
  • Proven experience leading and developing scientific teams and managing multiple programs and resources.

Nice to have

  • Experience in a CMO, CDMO, CRO, or other client-service organization.
  • Experience across multiple payloads or therapeutic applications, capability building or scaling, technology transfer, larger-scale or GMP manufacturing, or technical proposals and business development.

Pay

$213,000 - $280,500 (base salary)

Tools

LNP, mRNA, siRNA

AI focus

The role itself does not involve AI work; the posting states that applications may be reviewed using AI-assisted screening tools.

Model-written summary · the original posting is authoritative

First seen Oct 27, 2026 · Last verified Nov 5, 2026 (UTC)